رجوع
56
نطاق اليوم
KWD 0.19
KWD 0.19
نطاق 52 أسبوعًا
KWD 0.05
KWD 0.21
حجم التداول
300
متوسط 50 يوم / 200 يوم
KWD 0.18
/
KWD 0.12
الإغلاق السابق
KWD 0.19
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -7.9 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | -4.9 | 3.8 |
| Net Margin % | -11.4 | 3.9 |
| Rev Growth 5Y % | -6.3 | 10.0 |
| D/E | 0.2 | 0.2 |
النقاط الرئيسية
Revenue declined -6.28% annually over 5 years
Debt/Equity of 0.22 — conservative balance sheet
Generating 57.51M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.46%
Capital efficient — spends only 9.80% of revenue on capex
النمو
Revenue Growth (5Y)
-6.28%
Revenue (1Y)2.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-4.92%
ROIC-1.94%
Net Margin-11.40%
Op. Margin-7.27%
الأمان
Debt / Equity
0.22
Current Ratio1.73
Interest Coverage-0.50
التقييم
P/E Ratio
-7.87
P/B Ratio0.39
EV/EBITDAN/A
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.18% | Revenue Growth (3Y) | -6.64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.28% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.90B | Net Income (TTM) | -216.66M |
| ROE | -4.92% | ROA | -2.06% |
| Gross Margin | 65.32% | Operating Margin | -7.27% |
| Net Margin | -11.40% | Free Cash Flow (TTM) | 57.51M |
| ROIC | -1.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 1.73 |
| Interest Coverage | -0.50 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | -7.87 | P/B Ratio | 0.39 |
| P/S Ratio | 0.90 | PEG Ratio | -0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.05% |
| Market Cap | 1.71B | Enterprise Value | -942.07M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.90B | 1.86B | 2.18B | 3.04B | 2.46B |
| Net Income | -216.66M | -54.02M | -1.91B | 416.51M | 473.38M |
| EPS (Diluted) | -0.02 | -0.01 | -0.21 | 0.04 | 0.05 |
| Gross Profit | 1.24B | 1.30B | 1.49B | 2.43B | 1.91B |
| Operating Income | -138.13M | 161.70M | -1.83B | 771.95M | 787.13M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 10.53B | 11.54B | 12.14B | 14.50B | 13.04B |
| Total Liabilities | 5.58B | 6.40B | 6.50B | 5.35B | 3.10B |
| Shareholders' Equity | 4.37B | 4.43B | 4.74B | 8.28B | 9.19B |
| Total Debt | 974.01M | 1.26B | 1.29B | 1.08B | 755.05M |
| Cash & Equivalents | 3.62B | 3.89B | 3.83B | 5.68B | 4.60B |
| Current Assets | 5.72B | 6.20B | 6.55B | 7.74B | 6.40B |
| Current Liabilities | 3.31B | 4.11B | 2.53B | 2.50B | 2.44B |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#204 of 820
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026